AI-guided DNA switches for precise, safe, and adaptive cancer therapy
Project Overview
OncoSwitch is developing an AI-guided platform that designs DNA switches capable of activating therapeutic genes only in cancer cells while remaining silent in healthy tissue.
Our system integrates high-throughput MPRA data with machine learning to iteratively design, test, and optimize regulatory sequences.
Within 24 months, the platform aims to deliver 3–5 patentable DNA switches and launch collaborations with biotech and pharma partners.
Key Resources
Description
Type
Pitch Deck
Main project presentation
One-Pager
Project summary
Demo Video
1–2 min visual presentation
Our Core Team
Founder & CEO
Malika Gallyamova
- MSc Al & Computer Science, University of Birmingham
- Expert in networking and communications
- Experience managing teams and complex processes
Co-founder & CSO
Nadav Ahituv
- Professor in Bioengineering & Therapeutic Sciences
- Director, UCSF Institute for Human Genetics
- Expertise in functional genomics & gene therapy
Co-founder & CTO
Vitalii Volkov
- MSc Al & Computer Science, University of Birmingham
- Graduate of Pirogov Russian National Research Medical University
- Senior Bioinformatician
Get in Touch with Us
Oops! Something went wrong while submitting the form.
